{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:53:10Z","timestamp":1785894790831,"version":"3.56.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003100","name":"French Federation of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1053\/j.seminhematol.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:24:59Z","timestamp":1780759499000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The many facets of cardiopulmonary complications in sickle cell disease"],"prefix":"10.1053","volume":"63","author":[{"given":"Thomas","family":"d\u2019Humi\u00e8res","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain Le","family":"Jeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"de Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haytham","family":"Derbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihem","family":"Iles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lellouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Derumeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Mekontso Dessap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2026.05.007_bib0001","doi-asserted-by":"crossref","unstructured":"Hammoudi N, Montalescot G, Lionnet F, Redheuil A Cardiovascular manifestations of sickle cell disease. 2019 https:\/\/doi.org\/10.1093\/eurheartj\/ehz217","DOI":"10.1093\/eurheartj\/ehz217"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0002","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/asheducation-2017.1.423","article-title":"Cardiovascular complications in patients with sickle cell disease","volume":"2017","author":"Gladwin","year":"2017","journal-title":"Hematology"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0003","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-8703(72)90445-0","article-title":"Cardiovascular effects of anemia","volume":"83","author":"Varat","year":"1972","journal-title":"Am Heart J"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.blre.2015.08.005","article-title":"The role of blood rheology in sickle cell disease","volume":"30","author":"Connes","year":"2016","journal-title":"Blood Rev"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.70.4.357","article-title":"Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones","volume":"70","author":"Anand","year":"1993","journal-title":"Br Heart J"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.05.007_bib0006","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2011.10.900","article-title":"Cardiovascular abnormalities in sickle cell disease","volume":"59","author":"Gladwin","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.05.007_bib0007","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"issue":"14","key":"10.1053\/j.seminhematol.2026.05.007_bib0008","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jacc.2022.07.014","article-title":"The athlete\u2019s heart\u2014challenges and controversies: JACC focus Seminar 4\/4","volume":"80","author":"La Gerche","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2026.05.007_bib0009","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1182\/blood-2024-208896","article-title":"Unique nature of sickle cell diastolic cardiomyopathy: A tailored echocardiographic definition to refine prognostic stratification in young adults","volume":"144","author":"D\u2019Humieres","year":"2024","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0010","doi-asserted-by":"crossref","first-page":"E112","DOI":"10.1002\/ajh.24721","article-title":"Telomere attrition in sickle cell anemia","volume":"92","author":"Mekontso Dessap","year":"2017","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.05.007_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002095","article-title":"Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain","volume":"3","author":"Taylor","year":"2008","journal-title":"PloS One"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0012","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.05.007_bib0013","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/eurheartj\/ehz217","article-title":"Cardiovascular manifestations of sickle cell disease","volume":"41","author":"Hammoudi","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0014","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1532-429X-15-83","article-title":"Right and left ventricular function and myocardial scarring in adult patients with sickle cell disease: a comprehensive magnetic resonance assessment of hepatic and myocardial iron overload","volume":"15","author":"Junqueira","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172147","article-title":"Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome","volume":"12","author":"de Montalembert","year":"2017","journal-title":"PloS One"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.05.007_bib0016","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1182\/blood-2003-06-1919","article-title":"Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease","volume":"103","author":"Wood","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.05.007_bib0017","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ajh.26271","article-title":"Cardiovascular phenotypes predict clinical outcomes in sickle cell disease: an echocardiography-based cluster analysis","volume":"96","author":"d\u2019Humi\u00e8res","year":"2021","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0018","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcmg.2015.05.013","article-title":"Cardiomyopathy with restrictive physiology in sickle cell disease","volume":"9","author":"Niss","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2017-02-767624","article-title":"Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia","volume":"130","author":"Niss","year":"2017","journal-title":"Blood"},{"issue":"35","key":"10.1053\/j.seminhematol.2026.05.007_bib0020","doi-asserted-by":"crossref","first-page":"E5182","DOI":"10.1073\/pnas.1600311113","article-title":"Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology","volume":"113","author":"Bakeer","year":"2016","journal-title":"Proc Natl Acad Sci"},{"issue":"38","key":"10.1053\/j.seminhematol.2026.05.007_bib0021","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1005565","article-title":"A hemodynamic study of pulmonary hypertension in sickle cell disease","volume":"365","author":"Parent","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0023","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00134410","article-title":"Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease","volume":"39","author":"Fonseca","year":"2012","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.05.007_bib0024","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61689-w","article-title":"Cardiac diastolic maladaptation is associated with the severity of exercise intolerance in sickle cell anemia patients","volume":"14","author":"d\u2019Humi\u00e8res","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0026","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2006.09.038","article-title":"Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease","volume":"49","author":"Sachdev","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.05.007_bib0027","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.111.032920","article-title":"Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom","volume":"124","author":"Sachdev","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by Echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.05.007_bib0029","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/ajh.70073","article-title":"Early detection of diastolic dysfunction in sickle cell anemia: can it help the patient and let us see the elephant in the room?","volume":"100","author":"Coates","year":"2025","journal-title":"Am J Hematol"},{"issue":"36","key":"10.1053\/j.seminhematol.2026.05.007_bib0030","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.05.007_bib0031","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive Cardiomyopathy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ Res"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.05.007_bib0032","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/ajh.27348","article-title":"GLP-1 agonists and SGLT-2 inhibitors in adults with sickle cell disease","volume":"99","author":"Sun","year":"2024","journal-title":"Am J Hematol"},{"issue":"35","key":"10.1053\/j.seminhematol.2026.05.007_bib0033","doi-asserted-by":"crossref","first-page":"9670","DOI":"10.1073\/pnas.1611899113","article-title":"The heart in sickle cell disease, a model for heart failure with preserved ejection fraction","volume":"113","author":"Wood","year":"2016","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0034","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.2024025187","article-title":"Curative therapies raise the bar for the heart","volume":"144","author":"Wood","year":"2024","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood.2023023028","article-title":"Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease","volume":"144","author":"Sharma","year":"2024","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0036","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202509-2289ED","article-title":"10-Year longitudinal study clarifies impact of hemolysis and pulmonary hypertension on patients with sickle cell anemia","author":"Gladwin","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1005565","article-title":"A hemodynamic study of pulmonary hypertension in sickle cell disease","volume":"365","author":"Parent","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0038","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00134410","article-title":"Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease","volume":"39","author":"Fonseca","year":"2012","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.05.007_bib0039","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/rccm.201207-1222OC","article-title":"Hemodynamic predictors of mortality in adults with sickle cell disease","volume":"187","author":"Mehari","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0040","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202502-0353OC","article-title":"Cardiopulmonary hemodynamic determinants of long-term survival in Sickle cell disease: insights from the ETENDARD study","author":"Savale","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0041","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.05.007_bib0042","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2006-08-039438","article-title":"Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability","volume":"109","author":"Hsu","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0043","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0044","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00585-2019","article-title":"Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease","author":"Savale","year":"2019","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/rccm.201401-0065ST","article-title":"An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease","volume":"189","author":"Klings","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0046","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00272-2018","article-title":"Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease","volume":"52","author":"Turpin","year":"2018","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0047","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0048","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","article-title":"Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies","volume":"149","author":"Barst","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.05.007_bib0049","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/S2352-3026(24)00045-0","article-title":"Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial","volume":"11","author":"Gladwin","year":"2024","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12362","article-title":"Diagnosis and management of chronic thromboembolic pulmonary hypertension (CTEPH) in sickle cell disease: A review","volume":"14","author":"Hersi","year":"2024","journal-title":"Pulm Circ"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0051","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02828-2020","article-title":"ERS statement on chronic thromboembolic pulmonary hypertension","volume":"57","author":"Delcroix","year":"2021","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0052","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.21016","article-title":"Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency","volume":"83","author":"Gordeuk","year":"2008","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0053","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(96)00407-X","article-title":"Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia","volume":"102","author":"Pegelow","year":"1997","journal-title":"Am J Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.05.007_bib0054","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archinte.1981.00340070071015","article-title":"Arterial blood pressure in adults with sickle cell disease","volume":"141","author":"Johnson","year":"1981","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17474086.2022.2043743","article-title":"Factors associated with blood pressure variation in sickle cell disease patients: a systematic review and meta-analyses","volume":"15","author":"Nguweneza","year":"2022","journal-title":"Expert Rev Hematol"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.05.007_bib0056","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.115.021015","article-title":"Arterial stiffness impairment in sickle cell disease associated with chronic vascular complications","volume":"134","author":"Ranque","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0057","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ajh\/2.1.2","article-title":"Altered vascular reactivity in sickle hemoglobinopathy: A possible protective factor from hypertension","volume":"2","author":"Hatch","year":"1989","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0058","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000441-199303000-00004","article-title":"Is \u201crelative\u201d hypertension a risk factor for vaso-occlusive complications in Sickle Cell disease?","volume":"305","author":"Rodgers","year":"1993","journal-title":"Am J Med Sci"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.05.007_bib0059","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ehjcvp\/pvae084","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy?","volume":"11","author":"McCarthy","year":"2025","journal-title":"Eur Heart J - Cardiovasc Pharmacother"},{"issue":"16","key":"10.1053\/j.seminhematol.2026.05.007_bib0061","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2011-05-349621","article-title":"Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure","volume":"119","author":"DeBaun","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190347","article-title":"Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana","volume":"13","author":"Benneh-Akwasi Kuma","year":"2018","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066004","article-title":"Male gender, increased blood viscosity, body mass index and triglyceride levels are independently associated with systemic relative hypertension in sickle cell anemia","volume":"8","author":"Lamarre","year":"2013","journal-title":"PLOS ONE"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.05.007_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114309","article-title":"Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in Sickle cell disease","volume":"9","author":"Novelli","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00031","article-title":"Salbutamol worsens the autonomic nervous system dysfunction of children with sickle cell disease","volume":"11","author":"Bokov","year":"2020","journal-title":"Front Physiol"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.05.007_bib0066","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jash.2018.04.005","article-title":"Ambulatory hypertension in a pediatric cohort of sickle cell disease","volume":"12","author":"Moodalbail","year":"2018","journal-title":"J Am Soc Hypertens"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.05.007_bib0067","first-page":"e212","article-title":"Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Jones","year":"2025","journal-title":"Hypertension"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0068","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bcmd.2017.09.006","article-title":"Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia","volume":"69","author":"Yee","year":"2018","journal-title":"Blood Cells Mol Dis"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2026.05.007_bib0069","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1182\/blood-2020-142099","article-title":"The prevalence and impact of arrhythmias in hospitalized patients with sickle cell disorders: A large database analysis","volume":"136","author":"Kapoor","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0070","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/joa3.12418","article-title":"Sickle cell disease-associated arrhythmias and in-hospital outcomes: insights from the National Inpatient Sample","volume":"36","author":"Patel","year":"2020","journal-title":"J Arrhythmia"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.05.007_bib0071","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.2020005944","article-title":"IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias","volume":"137","author":"Gupta","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020381","article-title":"The role of inflammation in The cellular and molecular mechanisms of cardiopulmonary complications of sickle cell disease","volume":"13","author":"Gbotosho","year":"2023","journal-title":"Biomolecules"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.05.007_bib0073","article-title":"Electrocardiographic changes and their association with disease severity in adults with sickle cell anemia at a tertiary care center: A cross-sectional study","volume":"16","author":"Priyan","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0074","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ejh.12127","article-title":"Prolongation of QTc intervals and risk of death among patients with sickle cell disease","volume":"91","author":"Upadhya","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0075","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022019571","article-title":"Determinants of ventricular arrhythmias in sickle cell anemia: towards a better prevention of sudden cardiac death","author":"d\u2019Humi\u00e8res","year":"2023","journal-title":"Blood"},{"issue":"40","key":"10.1053\/j.seminhematol.2026.05.007_bib0076","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0077","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005521","article-title":"Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population","volume":"10","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"18","key":"10.1053\/j.seminhematol.2026.05.007_bib0078","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2019-316215","article-title":"Global longitudinal strain: clinical use and prognostic implications in contemporary practice","volume":"106","author":"Abou","year":"2020","journal-title":"Heart"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0079","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCEP.111.962381","article-title":"Left ventricular systolic dysfunction induced by ventricular ectopy","volume":"4","author":"Huizar","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"22","key":"10.1053\/j.seminhematol.2026.05.007_bib0080","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.jacc.2024.03.416","article-title":"Arrhythmia-induced cardiomyopathy","volume":"83","author":"Shoureshi","year":"2024","journal-title":"JACC"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0081","first-page":"360","article-title":"Clinical assessment of the risk for sudden cardiac death in patients with sickle cell anemia","volume":"100","author":"Fontaine","year":"2008","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0082","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/bjh.16314","article-title":"Sudden death in sickle cell disease: current experience","volume":"188","author":"Nze","year":"2020","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0083","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","article-title":"Causes of death in sickle cell disease: an autopsy study","volume":"123","author":"Manci","year":"2003","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.05.007_bib0084","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/CIRCEP.111.962043","article-title":"Sudden cardiac death in hypertrophic cardiomyopathy","volume":"6","author":"O\u2019Mahony","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0086","article-title":"Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacity","volume":"10","author":"Alsaied","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0087","first-page":"844","volume":"21","author":"Arnar","year":"2019","journal-title":"EP Eur"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0088","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1182\/bloodadvances.2024013208","article-title":"Atrial arrhythmia in sickle cell anemia adults: A missing link towards understanding and preventing strokes","volume":"8","author":"d\u2019Humi\u00e8res","year":"2024","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0089","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/bloodadvances.2024015307","article-title":"Key-role of long-duration cardiac rhythm monitoring in Sickle cell disease patients with atrial hyperexcitability","volume":"9","author":"Dang","year":"2025","journal-title":"Blood Adv"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.05.007_bib0090","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/STROKEAHA.115.010153","article-title":"First ischemic stroke in sickle-cell disease","volume":"46","author":"Calvet","year":"2015","journal-title":"Stroke"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.05.007_bib0091","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/ajh.25635","article-title":"Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era","volume":"94","author":"Kwiatkowski","year":"2019","journal-title":"Am J Hematol"},{"issue":"21","key":"10.1053\/j.seminhematol.2026.05.007_bib0092","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1182\/bloodadvances.2024014119","article-title":"Where there is smoke, there is fire: afib in SCD","volume":"8","author":"Uniat","year":"2024","journal-title":"Blood Adv"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0093","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029788","article-title":"Atrial fibrillation catheter ablation and rhythm control in patients with sickle cell disorders: A propensity score\u2013Matched analysis","volume":"13","author":"Gier","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.05.007_bib0094","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/jce.16713","article-title":"Multicenter experience of catheter ablation for atrial fibrillation in sickle cell anemia","volume":"36","author":"Moulin","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0095","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/CCM.0000000000000316","article-title":"Outcomes of adult patients with sickle cell disease admitted to the ICU: a case series*","volume":"42","author":"Cecchini","year":"2014","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0096","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02437-2","article-title":"Nationwide retrospective study of critically ill adults with sickle cell disease in France","volume":"11","author":"Agbakou","year":"2021","journal-title":"Sci Rep"},{"issue":"25","key":"10.1053\/j.seminhematol.2026.05.007_bib0097","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.05.007_bib0098","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002553","article-title":"Bedside lung ultrasound during acute chest syndrome in sickle cell disease","volume":"95","author":"Razazi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0099","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000821","article-title":"Positron emission tomography with 18F-fluorodeoxyglucose in patients with sickle cell acute chest syndrome","volume":"94","author":"de Prost","year":"2015","journal-title":"Med Baltim"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thoraxjnl-2013-203775","article-title":"Lung imaging during acute chest syndrome in sickle cell disease: computed tomography patterns and diagnostic accuracy of bedside chest radiograph","volume":"69","author":"Mekontso Dessap","year":"2014","journal-title":"Thorax"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0101","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ebiom.2016.06.038","article-title":"Score predicting acute chest syndrome during vaso-occlusive crises in adult sickle-cell disease patients","volume":"10","author":"Bartolucci","year":"2016","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.05.007_bib0102","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-104564","article-title":"High flow oxygen for vaso-occlusive crisis: a multicentre, prospective, randomised, multi-arm, multi-stage clinical trial (OSONE)","volume":"15","author":"Mekontso Dessap","year":"2025","journal-title":"BMJ Open"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0103","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00134-016-4472-7","article-title":"Ten tips for managing critically ill patients with sickle cell disease","volume":"43","author":"Mekontso Dessap","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0104","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1182\/bloodadvances.2025015947","article-title":"Severe parvovirus B19 infection in patients with sickle cell disease hospitalized in intensive care unit","volume":"9","author":"Gendreau","year":"2025","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0105","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1164\/ajrccm.153.5.8630622","article-title":"Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism","volume":"153","author":"Godeau","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0106","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1002\/ajh.25686","article-title":"Cerebral fat embolism in sickle cell disease","volume":"95","author":"Gendreau","year":"2020","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.05.007_bib0107","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.201105-0783OC","article-title":"Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease","volume":"184","author":"Mekontso Dessap","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0108","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/bjh.14914","article-title":"A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease","volume":"179","author":"Winchenne","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0109","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202409-1727OC","article-title":"Comparison of prophylactic and therapeutic doses of anticoagulation for acute chest syndrome in Sickle cell disease: the TASC randomized clinical trial","author":"Mekontso Dessap","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/SHK.0000000000000640","article-title":"Pulmonary vascular dysfunction and cor pulmonale during acute Respiratory distress syndrome in sicklers","volume":"46","author":"Cecchini","year":"2016","journal-title":"Shock Augusta Ga"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0111","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2141.2006.06417.x","article-title":"Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease","volume":"136","author":"Machado","year":"2007","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0112","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.200710-1606OC","article-title":"Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease","volume":"177","author":"Mekontso Dessap","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.05.007_bib0113","first-page":"2524","article-title":"Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension","volume":"25","author":"Audard","year":"2010","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13613-025-01479-3","article-title":"Guidelines for the management of emergencies and critical illness in pediatric and adult patients with sickle cell disease","volume":"15","author":"Mekontso Dessap","year":"2025","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.05.007_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302298","article-title":"Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome","volume":"19","author":"Razazi","year":"2024","journal-title":"PloS One"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0116","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/jac\/dky312","article-title":"Profound underdosing of \u03b2-lactams in patients with sickle-cell disease","volume":"73","author":"Cecchini","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0117","article-title":"Combined use of respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in sickle-cell adult patients with acute chest syndrome (The ANTIBIO-STA study): a randomised, controlled, open-label trial","volume":"51","author":"Sabat\u00e9-Elabbadi","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.05.007_bib0118","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113718","article-title":"Procalcitonin to reduce antibiotic exposure during acute chest syndrome in adult patients with sickle-cell disease","volume":"9","author":"Razazi","year":"2020","journal-title":"J Clin Med"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0119","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3324\/haematol.2021.280105","article-title":"Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysis","volume":"107","author":"Lopinto","year":"2022","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.05.007_bib0120","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM199509143331104","article-title":"Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases","volume":"333","author":"Bellet","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0121","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00134-010-1907-4","article-title":"Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study","volume":"36","author":"Fartoukh","year":"2010","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.05.007_bib0122","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00134-015-4141-2","article-title":"Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact","volume":"42","author":"Mekontso Dessap","year":"2016","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.05.007_bib0123","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00134-015-4060-2","article-title":"Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study","volume":"41","author":"Maitre","year":"2015","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/SHK.0000000000002593","article-title":"Prostacyclin-analog therapy for pulmonary vascular dysfunction during severe acute chest syndrome in sickle cell disease","volume":"64","author":"Lopinto","year":"2025","journal-title":"Shock Augusta Ga"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0125","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1097\/CCM.0000000000003628","article-title":"Extracorporeal life support for severe acute chest syndrome in adult sickle cell disease: A preliminary report","volume":"47","author":"Boissier","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0126","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1348077","article-title":"Refractory cor pulmonale under extracorporeal membrane oxygenation for acute respiratory distress syndrome: the role of conversion to veno-pulmonary arterial assist-a case series","volume":"11","author":"Bagate","year":"2024","journal-title":"Front Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.05.007_bib0127","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12265-012-9426-z","article-title":"Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problem","volume":"6","author":"Chacko","year":"2013","journal-title":"J Cardiovasc Transl Res"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2026.05.007_bib0128","article-title":"Absence of coronary artery disease in high-risk sickle cell anemia patients: a new illustration supporting the protective effect of Bilirubin against atherosclerosis?","volume":"45","author":"Stevenard","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0129","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211002914","article-title":"Antiphospholipid antibodies in Sickle cell disease: A systematic review and exploratory meta-analysis","volume":"27","author":"Merashli","year":"2021","journal-title":"Clin Appl Thromb"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.05.007_bib0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/jocs.13093","article-title":"Management of sickle cell disease in patients undergoing cardiac surgery","volume":"32","author":"Crawford","year":"2017","journal-title":"J Card Surg"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0131","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00277-009-0764-0","article-title":"Echocardiographic findings in patients with sickle cell disease","volume":"89","author":"Naoman","year":"2009","journal-title":"Ann Hematol"},{"issue":"14","key":"10.1053\/j.seminhematol.2026.05.007_bib0132","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/eurheartj\/ehv555","article-title":"Haematological determinants of cardiac involvement in adults with sickle cell disease","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1053\/j.seminhematol.2026.05.007_bib0133","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018506","article-title":"Degeneration of bioprosthetic heart valves: update 2020","volume":"9","author":"Kostyunin","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0134","doi-asserted-by":"crossref","DOI":"10.4103\/0971-9784.159806","article-title":"Heart valve surgery in patients with homozygous sickle cell disease: A management strategy","volume":"18","author":"Moutaouekkil","year":"2015","journal-title":"Ann Card Anaesth"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCULATIONAHA.109.882464","article-title":"Open heart surgery in patients with sickle cell hemoglobinopathy","volume":"121","author":"Yousafzai","year":"2010","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2026.05.007_bib0136","article-title":"Very premature bioprosthetic and valve repair degeneration in Sickle Cell disease patients","volume":"144","author":"Iles","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.05.007_bib0137","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/ehf2.12910","article-title":"Global longitudinal strain for prediction of ventricular arrhythmia in patients with heart failure","volume":"7","author":"Nikoo","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0138","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/hc0102.101396","article-title":"Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility","volume":"105","author":"Greenberg","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0139","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27768","article-title":"Sickle cell diastolic cardiomyopathy and mortality risk: A novel echocardiographic framework for prognostic stratification","author":"Simon","year":"2025","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.05.007_bib0140","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jama.2012.358","article-title":"Mortality in adults with sickle cell disease and pulmonary hypertension","volume":"307","author":"Mehari","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0141","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28973","article-title":"Sickle cell disease and ventricular myocardial strain: A systematic review","volume":"68","author":"Whipple","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.05.007_bib0142","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0143","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ajh.27297","article-title":"Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: A systematic review and meta-analysis","volume":"99","author":"Dovern","year":"2024","journal-title":"Am J Hematol"},{"issue":"19","key":"10.1053\/j.seminhematol.2026.05.007_bib0144","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1182\/bloodadvances.2019000387","article-title":"Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell disease","volume":"3","author":"Sachdev","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.05.007_bib0145","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood.2023023028","article-title":"Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease","volume":"144","author":"Sharma","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.05.007_bib0146","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.70161","article-title":"Haplo-identical stem cell transplant resolves ventricular arrhythmias and dysfunction in a sickle cell anemia patient: case report and discussion","volume":"6","author":"de Luna","year":"2025","journal-title":"EJHaem"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0147","doi-asserted-by":"crossref","first-page":"H429","DOI":"10.1152\/ajpheart.00417.2017","article-title":"Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea","volume":"315","author":"Bulmer","year":"2018","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.05.007_bib0148","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2141.2010.08109.x","article-title":"Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension","volume":"149","author":"Zorca","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.05.007_bib0149","article-title":"Plasma lipids and lipoproteins in sickle cell disease patients in the Northern West Bank","volume":"2021","author":"Samarah","year":"2021","journal-title":"Palestine BioMed Res Int"},{"key":"10.1053\/j.seminhematol.2026.05.007_bib0150","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202502-0353OC","article-title":"Cardiopulmonary hemodynamic determinants of long-term survival in Sickle cell disease: insights from the ETENDARD study","author":"Savale","year":"2025","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719632600051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719632600051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:34:23Z","timestamp":1785893663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003719632600051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S003719632600051X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.05.007","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The many facets of cardiopulmonary complications in sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}